Literature DB >> 15559724

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.

Suhair S Eid1, Ghada Rihani.   

Abstract

Thrombophilia is now considered a multi-causal condition, with interplay of acquired genetic risk factors. In order to estimate the frequency of the factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in the Jordanian population, we screened 200 healthy Jordanian individuals. 40% were females. Mean age was 32.1 years for males and 30.0 years for female participants. A PCR method detected 15.0% factor V Leiden (87% heterozygous, 13% homozygous), 2% prothrombin G20210A (100% heterozygous), and 24% MTHFR C677T (67% heterozygous, 33% homozygous). We conclude that the prevalence of factor V Leiden and MTHFR C677T is elevated in this population of Jordanians. However the incidence of G20210A is relatively low. Quantification of these genetic thrombosis risk factors in various populations will contribute to a better understanding of the interaction of genetic and environmental risk factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559724

Source DB:  PubMed          Journal:  Clin Lab Sci        ISSN: 0894-959X


  13 in total

1.  Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.

Authors:  Wassim Y Almawi; Sose H Keleshian; Lobna Borgi; Naglaa A Fawaz; Nisreen Abboud; Nabil Mtiraoui; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

2.  Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.

Authors:  R Dajani; A Arafat; N Hakooz; Z Al-Abbadi; Al-Motassem Yousef; M El Khateeb; F Quadan
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

Review 3.  'To test or not to test', the arguments for and against thrombophilia testing in obstetrics.

Authors:  Laura Ormesher; Louise E Simcox; Clare Tower; Ian A Greer
Journal:  Obstet Med       Date:  2017-03-08

4.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

5.  High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.

Authors:  Ayman S Hussein
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

6.  Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Authors:  Rana Dajani; Raja Fatahallah; Abdelrahman Dajani; Mohammad Al-Shboul; Yousef Khader
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

7.  Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

Authors:  Fatimah Madkhaly; Abdulaziz Alshaikh; Hala Aba Alkhail; Randa Alnounou; Tarek Owaidah
Journal:  Am J Blood Res       Date:  2021-06-15

8.  C677T MTHFR Gene Polymorphism is Contributing Factor in Development of Renal Impairment in Young Hypertensive Patients.

Authors:  Hanaa H Elsaid; Khaled A El-Hefnawy; Saffaa M Elalawi
Journal:  Indian J Clin Biochem       Date:  2020-05-14

9.  Association of inherited thrombophilia with recurrent pregnancy loss in palestinian women.

Authors:  N S Abu-Asab; S K Ayesh; R O Ateeq; S M Nassar; W A El-Sharif
Journal:  Obstet Gynecol Int       Date:  2011-06-14

10.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.